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In EXOG-depleted cardiomyocytes cell
death is marked by a decreased
mitochondrial reserve capacity of the
electron transport chain
Wardit Tigchelaar, Anne Margreet De Jong, Wiek H. van Gilst, Rudolf A. De Boer
and Herman H.W. Silljé*
Depletion of mitochondrial endo/exonuclease G-like (EXOG) in
cultured neonatal cardiomyocytes stimulates mitochondrial
oxygen consumption rate (OCR) and induces hypertrophy
via reactive oxygen species (ROS). Here, we show that neuro-
hormonal stress triggers cell death in endo/exonuclease
G-like-depleted cells, and this is marked by a decrease in
mitochondrial reserve capacity. Neurohormonal stimulation
with phenylephrine (PE) did not have an additive effect on
the hypertrophic response induced by endo/exonuclease
G-like depletion. Interestingly, PE-induced atrial natriuretic
peptide (ANP) gene expression was completely abolished in
endo/exonuclease G-like-depleted cells, suggesting a reverse
signaling function of endo/exonuclease G-like. Endo/exonucle-
ase G-like depletion initially resulted in increased mitochondrial
OCR, but this declined upon PE stimulation. In particular, the
reserve capacity of the mitochondrial respiratory chain and
maximal respiration were the first indicators of perturbations
in mitochondrial respiration, and these marked the subsequent
decline in mitochondrial function. Although pathological
stimulation accelerated these processes, prolonged EXOG de-
pletion also resulted in a decline in mitochondrial function. At
early stages of endo/exonuclease G-like depletion, mitochon-
drial ROS production was increased, but this did not affect mi-
tochondrial DNA (mtDNA) integrity. After prolonged depletion,
ROS levels returned to control values, despite hyperpolariza-
tion of the mitochondrial membrane. The mitochondrial dys-
function finally resulted in cell death, which appears to be
mainly a form of necrosis. In conclusion, endo/exonuclease
G-like plays an essential role in cardiomyocyte physiology.
Loss of endo/exonuclease G-like results in diminished adapta-
tion to pathological stress. The decline in maximal respiration
and reserve capacity is the first sign of mitochondrial dysfunc-
tion that determines subsequent cell death.
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Introduction
Cardiac hypertrophy is the cellular response to increased ven-
tricular wall stress and can be induced by a variety of patholog-
ical stimuli like hypertension, valvular disease and myocardial
infarction, and also by physiological stimuli including endurance
exercise and pregnancy [1–3]. Hypertrophy is deﬁned by an
increase in cardiomyocyte size and is accompanied by enhanced
protein synthesis and changes in sarcomere organization [4].
This response is initially an adaptive mechanism of the heart
to cope with this increased wall stress. However, hypertrophy
induced by sustained pathological stimulation, like neurohor-
monal stimulation, is not reversible and may become maladap-
tive. Under these conditions, the initially adaptive response of
compensated hypertrophy may advance into decompensated
hypertrophy and subsequently result in heart failure [5].
Hypertrophy is also accompanied by metabolic alterations
and changes in mitochondrial energy production in the muscle
cells, including altered substrate utilization [6, 7]. It is more
and more recognized that mitochondrial dysfunction is an im-
portant event in the development of heart failure [8]. This is
plausible, as the heart is the most energy-consuming organ
in the body and is largely dependent on mitochondrial metab-
olism to generate energy in the form of ATP to sustain proper
cardiac function [9]. Although the basic aspects of mitochon-
drial metabolism and energetics, including electron transfer
and ATP production, are well established, relatively little is
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known about the mechanisms and pathways leading to
mitochondrial energetic dysfunction in hypertrophy [10]. In
heart failure, the mitochondria in cardiomyocytes appear to
be intact but functionally impaired [8]. This provides opportuni-
ties for therapeutic interventions, but it will require a better un-
derstanding of genes and processes that affect mitochondrial
function.
Besides the role of mitochondria in providing energy, they
also generate reactive oxygen species (ROS). Under physiolog-
ical conditions, minor amounts of ROS are produced that can
be detoxiﬁed or act as signaling molecules [11]. Changes in
mitochondrial function can result in increased production of
ROS, triggering signal transduction pathways and/or resulting
in cellular damage [11]. In addition, mitochondria play a central
role in cell death mechanisms, including apoptosis and regu-
lated necrosis [12, 13]. Thus, mitochondria have a key position
in regulating and maintaining cellular functions.
Recently, we demonstrated that mitochondrial endo/
exonuclease G-like (EXOG) modulates mitochondrial respira-
tion and hypertrophy in cardiomyocytes [14]. Interestingly,
the EXOG-containing locus was previously identiﬁed in a
genome-wide association study on QRS duration, which is a
risk factor for heart failure [15]. Hence, we hypothesized that
perturbed EXOG function may affect human heart function.
We reported that in EXOG-depleted cardiomyocytes, mito-
chondrial respiration is strongly enhanced and a concomitant
increase in ROS has been observed. These increased ROS
levels triggered cell growth, resulting in a hypertrophic phe-
notype [14]. In clear contrast, in EXOG-depleted cancer cell
lines, mitochondrial DNA (mtDNA) damage was reported,
resulting in diminished mitochondrial respiration [16]. More-
over, in myoblasts, but not in myotubes, increased EXOG
levels were protective against oxidative stress [17]. Thus, it
appears that EXOG affects mitochondrial function in different
ways depending on the cell type and the cellular environ-
ment, including cellular stress. The role of EXOG under
cardiac stress and whether EXOG function is essential under
these conditions are not known. Cultured neonatal rat
ventricular cardiomyocytes (NRVCs) are an excellent in vitro
model to study cardiac stress conditions that mimic patholog-
ical hypertrophy, like adrenergic stimulation. So, in this study,
we investigated the role of EXOG under conditions of patholog-
ical cardiac stress in these non-proliferative cardiomyocytes. To
this aim, we stimulated EXOG-depleted cardiomyocytes with
phenylephrine (PE) and evaluated mitochondrial function,
including mitochondrial respiration and cell death.
Materials and methods
Isolation and culturing of primary cardiomyocytes
The use of animals for this study was in accordance with the Na-
tional Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals. The study was submitted to and approved
by the Committee for Animal Experiments of the University
of Groningen. Primary NRVCs were isolated from neonatal rats
of 1–3days old, as previously described [18, 19]. NRVCs
were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 5% fetal calf serum (FCS) and penicillin-
streptomycin (100UmL1 to 100μgmL1), and during the ﬁrst
day, 0.1mM BrdU was included to prevent proliferation of ﬁbro-
blasts. NRVCs were infected with recombinant adenoviral parti-
cles [multiplicity of infection (MOI) 50] 24hours after isolation
and serum starved in DMEM with penicillin-streptomycin
(100UmL1 to 100μgmL1) the next day. At this MOI, nearly
all cardiomyocytes become infected and express green ﬂuores-
cent protein (GFP), which is co-expressed with the short hairpin
RNAs (shRNA). Recombinant adenovirus expressing shRNAs
targeting EXOG or control shRNA virus (with a non-speciﬁc
sequence) have been described before [14]. Cells were infected
with virus for 72 or 144hours. Stimulation of cells with 50μM
PE was carried out after 24hours of starvation, resulting in 24
or 96hours of stimulation. Inhibitors Z-VAD fmk (carbobenzoxy-
valyl-alanyl-aspartyl-[O-methyl]-ﬂuoromethyl ketone) (20μM)
and MitoTEMPO (1μM) were added at the same time of infection.
All media and supplements were purchased from Sigma-Aldrich
Chemie B.V., Zwijndrecht, the Netherlands.
Hypertrophy measurements
Protein synthesis was measured via the incorporation of radio-
active labeled 3H-leucine, as described before [20].
For cell size measurements, NRVCs were grown on cover
slips coated with laminin (Millipore, Amsterdam, the Netherlands)
and cultured as described earlier. After ﬁxation for 10minutes
with paraformaldehyde, cells were permeabilized with 0.5%
Triton X. Cells were incubated with monoclonal anti-α-actinin
antibody (Sigma-Aldrich Chemie B.V.) in 1% bovine serum
albumin (BSA)/phosphate-buffered saline (PBS) for 1 hour at
room temperature (RT). Cells were washed and incubated for
another hour with Alexa-555 secondary antibody (Invitrogen Life
Technologies Europe B.V., Bleiswijk, the Netherlands). Cover
slips were mounted with mounting medium containing DAPI for
counterstaining of the nuclei, and slides were imaged using a
TissueFAXS (Axio Observer Z1 microscope, Carl Zeiss, Jena,
Germany), and cell size was determined by TISSUEQUEST ﬂuores-
cence analysis software.
Quantitative real-time polymerase chain reaction
Total RNA was isolated using a NucleoSpin RNA II kit (Bioké,
Leiden, the Netherlands), and cDNA was synthesized using
QuantiTect Reverse Transcription Kit (Qiagen, Venlo, the
Netherlands) following manufacturer’s instructions. Relative
gene expression was determined by quantitative real-time
polymerase chain reaction (qRT-PCR) on the Bio-Rad CFX384
real-time system (Bio-Rad, Veenendaal, the Netherlands) using
ABsolute qPCR SYBR Green Mix (Thermo Scientiﬁc, Landsmeer,
the Netherlands). NPPA [atrial natriuretic peptide (ANP)] gene
expression was corrected for reference gene values (36B4)
and expressed relative to the control group. Primer sequences
included ANP forward atgggctccttctccatcac, ANP reverse
tctaccggcatcttctcctc, 36B4 forward gttgcctcagtgcctcactc and
36B4 reverse gcagccgcaaatgcagatgg.
Seahorse mitochondrial flux analyses
To determine oxygen consumption rate (OCR) in cardiomyocytes,
a Seahorse metabolic ﬂux analyzer (Seahorse Bioscience, North
Billerica, MA, USA) was used as previously described [21].
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Neonatal cardiomyocytes were seeded at a density of
100,000 cells per well in special Seahorse 24-well plates. Cells
were adenoviral infected and treated as described earlier. One hour
before initiation of the Seahorse measurements, medium was re-
placed with XF medium supplemented with 10mM glucose and in-
cubated for 1hour in a CO2-free 37°C incubator. Basal respiration of
cells was measured, followed by injection of oligomycin (ATP syn-
thase inhibitor) (1μM) tomeasure ATP-linkedOCR. The uncoupler car-
bonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone (FCCP) (0.5μM)
was used to determine maximal respiration. Finally, rotenone
(1μM) and antimycin A (1μM), inhibiting complexes I and III, respec-
tively, were injected to determine the non-mitochondrial respiration.
In each plate, the same treatment was performed in triplicate or qua-
druplicate. OCR was corrected for the amount of total protein in each
well.
DNA damage
Total DNA including mtDNA was extracted from cells using the
DNeasy Blood & Tissue Kit (Qiagen), and DNA purity and quan-
tity were determined by spectroscopic analysis. The isolated
DNA showed high purity (A260/A280> 1.8). The D-loop mito-
chondrial genomic region was ampliﬁed by PCR because this
part of the mitochondrial genome is described to be the most
susceptible to DNA damage [22]. This was performed with a
semi-long-run qRT-PCR as described before [14, 22].
Determination of mitochondrial membrane potential
Mitochondrial membrane potential (ΔΨm) was assessed by
tetramethylrhodamine ethyl ester (TMRE), as described before [21].
In brief, cells were seeded at a density of 40,000 cells per well in a
black 96-well plate and cultured as described earlier. TMRE
(100nM) was added and incubated for 20minutes at 37°C. Cells
were subsequently washed with 0.2% BSA in PBS, and ﬂuorescence
was measured at an excitation of 549nm and emission of 575nm
with a SynergyH4 Hybrid Reader (BioTek, Winooski, VT, USA). As
a control, FCCP (1μM) was used to eliminate mitochondrial mem-
brane potential. Each experiment was measured in quadruplicate.
Mitochondrial ROS
Mitochondrial ROS production was determined using MitoSOX
red mitochondrial superoxide indicator (Molecular Life Technolo-
gies Europe B.V., Bleiswijk, the Netherlands) as described be-
fore [21]. Brieﬂy, cells were plated in 96-well plates and
cultured as described earlier. Cells were subsequently incubated
with MitoSOX (2.5μM) in Krebs-Ringer-Phosphate-HEPES (KRPH)
buffer (20mM HEPES, 5mM KH2PO4, 1mM MgSO4, 1mM CaCl2,
136mM NaCl, 4.7mM KCl pH7.4) for 10minutes at 37 °C and
thereafter washed three times with the same buffer. Fluores-
cence was measured using excitation/emission maxima of
510/580nm with a SynergyH4 Hybrid Reader (BioTek).
Microscopic analysis of cell death
For counting dead cells, NRVCs were grown and treated as
described earlier. Cells were incubated with Hoechst 33342
(2μgμL1) and propidium iodide (PI; 3μgμL1) and imaged
using Leica DM6000. PI-positive dead cells relative to total
cells (Hoechst positive) were determined per ﬁeld.
For counting apoptotic cells, NRVCs were ﬁxed for 10minutes
with 4% paraformaldehyde at 4 °C, followed by permeabilization
with 0.5% Triton X for 5minutes. Cells were incubated with
monoclonal anti-cleaved caspase 3 antibody (Sigma-Aldrich
Chemie B.V.) in 1% BSA, 2% normal goat serum and 0.1% Tween
in PBS for 1hour at RT. Cells were washed with PBS and incubated
for another hour with a goat anti-mouse Fluorescein isothiocyanate
(FITC) secondary antibody (Santa-Cruz Biotechnology, Heidelberg,
Germany). Cover slips were mounted with mounting medium
containing DAPI (Vector Laboratories, Burlingame, CA, USA) for
counterstaining of the nuclei. Slides were imaged using Leica
DM6000, and cleaved caspase-positive cells were counted, rela-
tive to the total amount of cells per ﬁeld.
Lactate dehydrogenase activity
Lactate dehydrogenase (LDH) is a cytosolic enzyme that is an indi-
cator of cellular toxicity and was monitored by the LDH release
assay. LDH activity was determined in cell culture medium using
the Roche International Federation of Clinical Chemistry (IFCC)
liquid assay on the modular analysis according to the manufac-
turer’s instructions (Roche, Mannheim, Germany).
Statistical analysis
All values are presented as means ± standard errors of the mean
(SEM). Independent-samples t-test was performed to compare
the difference between two groups. One-way analysis of variance
(ANOVA) with post hoc Bonferroni test was used to compare the
difference between multiple groups. p<0.05 was considered to
be signiﬁcant. SPSS software (PASW Statistics 22, IBM Corpora-
tion, Armonk, NY, USA) was used for the statistical analyses.
Results
EXOG depletion and PE induce hypertrophy in neonatal
cardiomyocytes
We have recently shown that EXOG depletion stimulates mito-
chondrial respiration and causes ROS-mediated cardiomyocyte
hypertrophy [14]. This is surprising because EXOG is known
as an mtDNA repair enzyme and protects the mitochondrial
genome from oxidative stress in a proliferating myoblast cell
line [16, 17]. We therefore decided to investigate whether EXOG
would have more critical effects in cardiomyocytes under stress
conditions by neurohormonal stimulation with PE. We ﬁrst
assessed hypertrophy development in EXOG-depleted NRVCs
in the presence and absence of PE. As shown in Fig. 1, both
EXOG depletion and PE stimulation generated a hypertrophic
response indicated by increased protein synthesis (Fig. 1A)
and cell size (Fig. 1B). Although in PE the stimulated EXOG-
depleted cells protein synthesis appeared somewhat higher
than in PE-stimulated control cells, this difference was not
signiﬁcant (Fig. 1A). The increase in cell size in EXOG-depleted
cells, as determined using microscopy, was similar to that
of PE stimulation in control cells (Fig. 1B). EXOG depletion
did not signiﬁcantly augment the PE-induced hypertrophic
response. The mRNA expression of the established pathologi-
cal hypertrophic marker ANP was also determined. Stimulation
of NRVC with PE signiﬁcantly induced ANP expression, whereas
W. Tigchelaar et al. Primary Research ■






EXOG depletion had no effect on ANP expression. Surprisingly,
EXOG depletion fully prevented PE-mediated ANP expression
(Fig. 1C). Thus, EXOG appears to be modulating pathological
ANP gene expression under these conditions.
EXOG depletion reduces maximal respiration and reserve
capacity in PE-stimulated cells
Stimulation of NRVC with PE and depletion of EXOG both stimu-
late mitochondrial respiration in NRVCs [14, 21], but whether
these effects are interdependent is not known. Here, we investi-
gated the combined response on metabolic respiration of NRVCs
to stimulation with PE and 72hours of EXOG depletion. EXOG
depletion increased mitochondrial respiration and ATP-linked
respiration (Fig. 2A, B). Although not signiﬁcant, an increase in
maximal respiration, induced with the uncoupler FCCP, and the
reserve capacity, which is the difference between maximal respi-
ration and mitochondrial respiration, was observed (Fig. 2A, B).
Also, PE stimulation resulted in an increase in respiration as
compared with control cells (Fig. 2C). EXOG depletion did not
show an additive effect on mitochondrial respiration in the pres-
ence of PE. In contrast, EXOG depletion resulted in a strong
attenuation of PE-induced maximal respiration and reserve
capacity (Fig. 2C, D). Despite this attenuation, ATP-linked respi-
ration was maintained (Fig. 2D), and these cells still showed a
normal hypertrophic response (Fig. 1A and B), indicating viable
cells. Thus, stimulation with PE of EXOG-depleted cells does
not have additive effects on mitochondrial respiration, and the
diminished increase in maximal respiration and reserve capacity
may suggest detrimental rather than positive effects of EXOG
depletion under these pathological conditions.
Mitochondrial respiration is decreased upon prolonged
PE stimulation of depleted cells
The reserve capacity is believed to be an important determi-
nant in coping with cellular stress [23, 24]. Because EXOG-
depleted cells showed a decreased reserve capacity after
stimulation with PE, this may provide a ﬁrst indication that
EXOG-depleted cells are unable to adapt properly to changes
induced by this pathological stress factor. As shown in
Supporting Information Figure 1, EXOG depletion remained
constant for at least 144 hours, and we therefore decided to in-
vestigate mitochondrial function at later time points after EXOG
depletion. In Fig. 3A and B, it is shown that mitochondrial OCR
is strongly declined in cells that are EXOG depleted for
144 hours and stimulated with PE, as compared with control
PE-stimulated cells. Also, maximal respiration, reserve capacity
and ATP-linked OCR were strongly declined, indicating that
mitochondrial respiration was strongly hampered at this time
point. To exclude the effect of differences in cell number and
cell size, the OCR values were corrected for amount of protein
per well. To investigate whether this was not solely an effect
of EXOG depletion, OCR of EXOG-depleted cells at the same
moment was measured. Although these cells also showed a
decline in cellular respiration, mitochondrial-speciﬁc OCR and
ATP-linked OCR were still comparable with the control cells,
but reserve capacity and maximal respiration were lower, albeit
not signiﬁcantly (Fig. 3C and D). Thus, prolonged EXOG deple-
tion resulted in mitochondrial dysfunction, and this was
strongly exacerbated by stimulation with PE.
Depletion of EXOG did not result in mtDNA damage but
increased mitochondrial membrane potential
As the function of EXOG has been linked to DNA repair mecha-
nisms [16], we investigated whether the decline in OCR after PE
stimulation of prolonged EXOG-depleted NRVCs could be
explained by an increase in mtDNA damage. We performed a
semi-long-run PCR to detect mtDNA damage lesion. mtDNA
damage was not increased between the different conditions,
indicating that the decline in mitochondrial function was not
a result of mtDNA damage (Fig. 4A and B). As shown, before,
EXOG depletion did not also affect the mtDNA/nDNA ratio
(Supporting Information Figure 2).
Loss of the proton motive force, the pH gradient and mem-
brane potential will result in the loss of ATP synthesis via oxida-
tive phosphorylation and result in cell death. Therefore, we
investigated this potential using TMRE ﬂuorescence. After
72hours of EXOG depletion, we did not observe any signiﬁcant
changes in membrane potential between EXOG-depleted cells,
PE-stimulated cells and the combination of both (Fig. 4C). After
prolonged depletion of EXOG, the membrane potential was even
increased both in the presence and in the absence of PE (Fig. 4D).
A B C
Figure 1. Effects of EXOG depletion on PE-induced hypertrophic responses. Neonatal rat ventricular cardiomyocytes were infected with con-
trol or EXOG-specific shRNA expressing adenovirus for 72 hours and stimulated with or without PE for 24 hours. EXOG silencing is indicated
as siEXOG. A: Protein synthesis was determined by leucine incorporation (N = 12). B: Cell surface area was measured using a TissueFAXS
(N = 9–6). C: Gene expression of the hypertrophic marker ANP was determined by RT-PCR (N = 7–11). All graphs depict means and SEM, and
a one-way ANOVA with post hoc Bonferroni test was used to compare the difference between multiple groups. *p< 0.05 as compared with
control; #p< 0.05 as compared with control with PE; $p< 0.05 as compared with siEXOG.
■ Primary Research W. Tigchelaar et al.




We wondered whether this increase in mitochondrial mem-
brane potential was associated with increased ROS production.
As shown in Fig. 4E, EXOG depletion increased ROS production,
and this response was exacerbated after stimulation with PE.
However, after 144 hours of EXOG depletion, this increased
ROS production was diminished (Fig. 4F). Thus, although
initially an increased ROS production is observed, most likely
as a result of increased ﬂux, this high ROS production is not
maintained.
Prolonged depletion of EXOG causes cell death, which is
enhanced by pathological stimulation
As mitochondrial dysfunction is apparent, we next investigated
if prolonged EXOG depletion induced cell death. We microscop-
ically determined cell numbers and observed no obvious
change within the ﬁrst 72 hours of depletion, also not in the
presence of PE (Fig. 5A and B). However, prolonged depletion
of EXOG signiﬁcantly decreased cell numbers. Again, this effect
was strongly exacerbated in PE-stimulated EXOG-depleted cells
(Fig. 5A and C). Under these conditions, we observed a higher
number of ﬁbroblasts, which was merely a result of decreased
numbers of cardiomyocytes.
To corroborate this ﬁnding, we also stained the cells with
PI, which stains nuclei of dead cells. Hoechst was used as a
counterstain, which stains nuclei of all cells. As expected,
no increase in PI-positive cells was observed after 72 hours
of EXOG depletion, with or without stimulation with PE
(Fig. 5D). An increase in PI-positive cells was observed after
144 hours of EXOG depletion and was more elevated with PE
(Fig. 5E).
Prolonged depletion of EXOG results in cell death with
features of necrosis
As PI can stain the nuclei of both late apoptotic and necrotic
cells, we next investigated whether programmed cell death
via apoptosis occurred. NRVCs were stained with an antibody
Figure 2. Effect of EXOG depletion on cellular oxygen consumption rate (OCR). OCR was measured in a Seahorse XF24 extracellular flux
analyzer in NRVC. Glucose (10mM) was used as a substrate. A: Total OCR was measured in cells infected for 72 hours with control or
siEXOG adenovirus; addition of oligomycin (ATP synthase inhibitor), FCCP and antimycin A and rotenone (respiration inhibitor) is indicated. B:
Quantification of mitochondrial OCR (Mito), maximal OCR (Max.), reserve capacity (Res.Cap.) and ATP-linked OCR (ATP) of the conditions
shown in A relative to mitochondrial OCR of control cells. Mitochondrial OCR is the difference between the basal respiration and the OCR after
addition of respiration inhibitor; maximal respiration is defined as the OCR induced after FCCP injection; reserve capacity is calculated as the
difference betweenmaximal respiration and basal respiration; and the ATP-linked OCR is defined as oligomycin-sensitive OCR (N= 6–9).C: Total
OCR measurements, comparable with those shown in A, except that cells were also stimulated with PE for 24hours. D: Quantification of the
graph shown in C, relative to mitochondrial OCR of control cells. OCR was corrected for total protein levels in each well, and all measurements
were performed at least in triplicates. All graphs depict means and SEM; independent-samples t-test was performed to compare the difference
between both groups. *p< 0.05 as compared with control; #p< 0.05 as compared with control with PE. EXOG silencing is indicated as siEXOG.
W. Tigchelaar et al. Primary Research ■






against cleaved caspase 3, which is the activated form of
caspase 3, and this is a well-known marker for apoptosis. This
did not show an increase in apoptotic cells under the different
conditions (Fig. 6A and B). Western blotting revealed, however,
a faint cleaved caspase 3 band after overexposure of the blot,
but this was not different between control and EXOG-depleted
cells (Supporting Information Figure 3). No speciﬁc increase
of cleaved caspase 3 in EXOG-depleted cells was observed.
Also, Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) staining was performed, and positive nuclei
could be detected in the NRVC cultures, but these were always
devoid of cytoplasmic staining (Supporting Information
Figure 4). This is suggestive of nuclear remnants of dead cells
and not of early apoptotic cells. Also, late necrotic cells become
TUNEL cardiomyocytes and become TUNEL positive [25]. NRVCs
could be detected in the EXOG PE-treated cultures that showed
abnormal shrinkage and are probably dying cells, but these were
always TUNEL negative (Supporting Information Figure 4A). Cells
were also treated with the pan caspase inhibitor Z-VAD fmk
(20μM). Treatment of the cells with this inhibitor did not affect
the cells after 72hours of EXOG depletion. Moreover, Z-VAD fmk
did not inhibit EXOG depletion-induced cell death after 144hours
(Fig. 6C and D). All together, these data suggest that apoptosis is
not a major driver of cell death in EXOG-depleted cells.
As ROS production was increased in EXOG-depleted cells,
we treated the cells with the ROS scavenger MitoTEMPO as
high ROS levels also might induce cell death. As shown in
Fig. 6E and F, MitoTEMPO had no effect on the EXOG-depleted
cells after 72 hours of silencing and also did not prevent
prolonged EXOG depletion-induced cell death.
Another major cell death mechanism in cardiomyocytes is ne-
crosis. Necrotic cell death is characterized by loss of cytoplasmic
content, and the presence of extracellular LDH activity is a clear
sign of necrosis [26]. LDH activity signiﬁcantly increased after
prolonged depletion of EXOG, and the activity was further
increased in combination with PE (Fig. 6G and H). This suggests
that prolonged EXOG depletion caused necrosis, and, again, this
was strongly augmented by PE.
Figure 3. Effect of prolonged EXOG depletion on cellular oxygen consumption rate (OCR). OCR was measured using the same protocol as
used in Fig. 2. A: Total OCR was measured in cells infected for 144 hours, with control or siEXOG virus stimulated with PE for 96 hours (N = 6).
B: Quantification of mitochondrial OCR (Mito), maximal OCR (Max.), reserve capacity (Res.Cap.) and ATP-linked OCR (ATP) of the conditions
shown in A, relative to mitochondrial OCR of control cells (N = 6). C: Total OCR was measured in cells infected for 144 hours with control or
siEXOG adenovirus (N = 6). D: Quantification of mitochondrial OCR (Mito), maximal OCR (Max.), reserve capacity (Res.Cap.) and ATP-linked
OCR (ATP) of the conditions shown in C, relative to mitochondrial OCR of control cells (N= 6). OCR was corrected for total protein levels in
each well, and all measurements were performed at least in triplicates. All graphs depict means and SEM; independent-samples t-test was
performed to compare the difference between both groups. #p< 0.05 as compared with control with PE. EXOG silencing is indicated as
siEXOG.
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In this study, we show that EXOG is an important gene in
cardiomyocytes and that cell death is enhanced in EXOG-
depleted cells treated with the pathological stress factor PE. We
have recently shown that EXOG depletion activated mitochon-
drial respiration and induced ROS-mediated hypertrophy [14].
We conﬁrmed these ﬁndings here but now also investigated
the effects of prolonged EXOG depletion and the effects of EXOG
depletion under pathological stress conditions. These results
show that EXOG is important to maintain homeostasis in
cardiomyocytes, but this is not related to its purported function
in maintaining mtDNA integrity. EXOG depletion ﬁrst resulted in
improved mitochondrial respiration, but in time, and particularly
after PE stimulation, mitochondrial respiration declined. Interest-
ingly, diminished maximal respiration and reserve capacity were
the ﬁrst signs of mitochondrial dysfunction in these cells
resulting in cellular death. Although we do not know the mecha-
nisms underlying these changes, it is highly interesting that
depletion of EXOG ﬁrst stimulates mitochondrial function and
cell growth but, in the long run, results in mitochondrial dysfunc-
tion and cell death.
Initially, mitochondrial respiration in EXOG-depleted cells
was increased, but prolonged depletion resulted in a decrease
in respiration, and this is more pronounced in the presence of
PE. The decline in maximal respiration and reserve capacity
was the ﬁrst sign that mitochondrial respiration was hampered
in EXOG-depleted cells stimulated with PE, which ultimately
resulted in cell death. Previously, the metabolic reserve capac-
ity was shown to be important for maintaining cellular function
during acute and chronic stress [23]. In endothelial cells, the
exhaustion of the reserve capacity by ROS leads to mitochon-
drial protein modiﬁcations, ultimately resulting in cell death
[27, 28]. As the ROS scavenger MitoTEMPO did not prevent cell
death in EXOG-depleted cardiomyocytes, it appears unlikely
that the initial higher levels of ROS are responsible for cell
death under these conditions. As EXOG depletion-induced
ROS production could not be decreased by treatment with
MitoTEMPO, we suggest that increased ROS levels are impli-
cated in several other effects on the cell, including cardiac hy-
pertrophy [14]. Apparently, this is a more direct effect of EXOG
on mitochondrial function and maintaining reserve capacity.
Although reserve capacity is still a vague term and its exact role
is not clear, it probably provides cells with the ﬂexibility to
adapt to changing conditions. Our result that diminishment of
reserve capacity in EXOG-depleted cells is the ﬁrst sign in a
process leading to cell death underscores the importance of
the reserve capacity. It will therefore be very interesting to
investigate whether a decline in reserve capacity is in general
a ﬁrst sign that marks subsequent cell death.
Cell death in EXOG-depleted cells did not appear to be an ef-
fect of enhanced stress levels. On the contrary, expression of the
cardiac stress marker ANP did not signiﬁcantly change in EXOG-
depleted cells and was even diminished in EXOG-depleted cells
in the presence of PE as compared with control PE-treated cells.
Also oxidative stress markers (catalase and MnSOD) were
Figure 4. Effect of EXOG depletion on mtDNA damage, mitochondrial membrane potential and ROS production. Cells were stimulated with or
without PE and infected with control or EXOG silencing adenovirus (siEXOG) for the indicated time. A and B: Mitochondrial DNA damage was
measured using RT-PCR after 72 hours silencing (A) or 144 hours (B) (N = 5–11). C and D: Mitochondrial membrane potential was measured
using TMRE after 72 hours silencing (C) or 144 hours (D) (N = 4–6). E and F: Mitochondrial superoxide production was measured using
MitoSOX after 72 hours silencing (E) or 144 hours (F) (N = 10–14). Fluorescence was measured in quadruplicates per experiment. All graphs
depict means and SEM; a one-way ANOVA with post hoc Bonferroni test was used to compare the difference between multiple groups.
*p< 0.05 as compared with control; #p< 0.05 as compared with control with PE; $p< 0.05 as compared with siEXOG.
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notincreased in EXOG-depleted cells [14]. Although we cannot
rigorously exclude activation of other stress markers, it may
indicate that there is no increased stress level in these cells.
However, as an alternative hypothesis, EXOG depletion may also
prevent activation of protective stress responsive pathways and
consequently drives cells into cell death under stress conditions.
ANP has cardiomyocyte protective actions via cGMP-mediated
signaling [29], but its expression is repressed in EXOG-depleted
cells. Although it will be difﬁcult to discriminate between these
two possibilities, further investigation of how EXOG may affect
stress levels or stress protection will be highly relevant.
A multitude of mitochondrial alterations is observed in a
temporal manner in EXOG-depleted cells, and these can be en-
hanced by PE stimulation. Whereas depletion of EXOG ﬁrst
stimulates mitochondrial OCR, in time, a decline is observed.
ROS production is ﬁrst increased but normalizes later, whereas
mitochondrial potential is ﬁrst comparable with control cells
but increases at later stages. These pleiotropic responses
make it very difﬁcult to determine the direct effects of EXOG,
and most mitochondrial processes are strongly interlinked.
The mitochondrial membrane potential (Δψ), for example,
controls ATP synthesis, generation of ROS, mitochondrial
Figure 5. Effect of EXOG depletion on cell death. Cells were stimulated with or without PE and infected with control or EXOG silencing ad-
enovirus (siEXOG) for the indicated time. A: Representative images of control and EXOG-depleted cells with and without PE. B and C: Cells
were stained with Hoechst, and total cells per field were counted after 72 hours (B) or 144 hours (C) silencing. For quantification, at least 150
cells were counted per experiment (N= 6–8). D and E: Cells were stained with propidium iodide (PI) and counterstained with Hoechst. PI-positive
cells were counted and corrected for total cells per field after 72hours of silencing (D) or 144 hours (E) (N= 6). All graphs depict means and SEM;
a one-way ANOVA with post hoc Bonferroni test was used to compare the difference between multiple groups. *p< 0.05 as compared with
control; #p< 0.05 as compared with control with PE; $p< 0.05 as compared with siEXOG.
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calcium sequestration, import of proteins into the mitochon-
drion and mitochondrial membrane dynamics [30, 31]. Con-
versely, Δψ is controlled by ATP utilization, mitochondrial
proton conductance, respiratory chain capacity and mitochon-
drial calcium [31, 32]. So, it is difﬁcult to interpret the single
events, and the increased Δψ observed at later time points
could be a result of many different factors. This high Δψ
is, however, in agreement with the absence of apoptosis,
which is accompanied by MPTP opening and consequently a
decreased Δψ.
Figure 6. EXOG depletion results in cell death via necrosis. A and B: Cells were stained with specific cleaved caspase 3 antibody, and positive
cells were counted after 72 hours of silencing (A) or 144 hours (B) (N= 6–8). C and D: Cells were treated with the pan caspase inhibitor Z-VAD
fmk, cells were stained with Hoechst and total cells per field were counted after 72hours of silencing (C) or 144 hours (D) (N= 4–8). E and F: Cells
were treated with the ROS scavenger MitoTEMPO, cells were stained with Hoechst and total cells per field were counted after 72 hours silencing
(E) or 144 hours (F) (N= 4–8). G andH: LDH activity was measured in cell culture medium after 72hours of silencing (G) or 144 hours (H) (N= 4–6).
All graphs depict means and SEM; a one-way ANOVA with post hoc Bonferroni test was used to compare the difference between multiple
groups. *p< 0.05 as compared with control; #p< 0.05 as compared with control with PE; $p< 0.05 as compared with siEXOG. EXOG silencing
is indicated as siEXOG.
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All together, our results show that in neonatal cardiomyocytes,
loss of EXOG initially enhances mitochondrial function and in-
duces cell growth, but in time, mitochondrial function declines.
This is not a result of mtDNA damage or induction of apoptosis
but a result of mitochondrial dysfunction resulting in cell death,
which can be enhanced by pathological stimulation. Most inter-
estingly, a decline in mitochondrial reserve capacity is the ﬁrst
sign of mitochondrial dysfunction under these conditions.
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